Your browser does not fully support modern features. Please upgrade for a smoother experience.
Reuptake Inhibitors: History
Please note this is an old version of this entry, which may differ significantly from the current revision.
Contributor: Yu Peng

Reuptake inhibitors are compounds that reduce the transporter-mediated return of released neurotransmitters from extracellular spaces into neurons or glial cells [1][2]. By slowing this clearance route, they can increase neurotransmitter availability near receptors and prolong extracellular signaling. Major targets include the serotonin, norepinephrine, and dopamine transporters, which use transmembrane ion gradients to drive neurotransmitter uptake. Individual inhibitors differ in their relative activity at these transporters, producing selective or combined inhibition profiles [1]. Structural studies show that several serotonin reuptake inhibitors occupy the central substrate-binding site and stabilize an outward-open transporter conformation, preventing normal serotonin binding and transport [3][4]. The broader category also includes inhibitors of non-monoamine transporters: glycine transporter 1 can be inhibited by compounds that stabilize an inward-open state [2]. Reuptake inhibition therefore describes interference with a transport process rather than a single binding geometry. Its immediate action is distinct from neurotransmitter synthesis inhibition, transmitter degradation blockade, or direct activation of a neurotransmitter receptor [1][2].

  • neurotransmitter transporter
  • serotonin transporter
  • monoamine reuptake
  • glycine transporter

Pharmacological Effects and Toxicity Studies • Pediatrics, Perinatology and Child Health • Medicine • Health Sciences

References

  1. Mary Hongying Cheng; Ivet Bahar; Monoamine transporters: structure, intrinsic dynamics and allosteric regulation. Nat. Struct. Mol. Biol. 2019, 26, 545-556. [CrossRef]
  2. Azadeh Shahsavar; Peter Stohler; Gleb Bourenkov; Iwan Zimmermann; Martin Siegrist; Wolfgang Guba; Emmanuel Pinard; Steffen Sinning; Markus A. Seeger; Thomas R. Schneider; Roger J. P. Dawson; Poul Nissen; Structural insights into the inhibition of glycine reuptake. Nature 2021, 591, 677-681. [CrossRef]
  3. Jonathan A. Coleman; Evan M. Green; Eric Gouaux; X-ray structures and mechanism of the human serotonin transporter. Nature 2016, 532, 334-339. [CrossRef]
  4. Jonathan A. Coleman; Eric Gouaux; Structural basis for recognition of diverse antidepressants by the human serotonin transporter. Nat. Struct. Mol. Biol. 2018, 25, 170-175. [CrossRef]
More
This entry is offline, you can click here to edit this entry!
Write an Entry